Agustin Calatroni
Overview
Explore the profile of Agustin Calatroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
3159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wood R, Togias A, Sicherer S, Shreffler W, Kim E, Jones S, et al.
N Engl J Med
. 2024 Feb;
390(10):889-899.
PMID: 38407394
Background: Food allergies are common and are associated with substantial morbidity; the only approved treatment is oral immunotherapy for peanut allergy. Methods: In this trial, we assessed whether omalizumab, a...
12.
Keet C, Sicherer S, Bunyavanich S, Visness C, Fulkerson P, Togias A, et al.
J Allergy Clin Immunol Glob
. 2023 Sep;
2(3).
PMID: 37771674
Background: Food allergy (FA) and atopic dermatitis (AD) are common conditions that often present in the first year of life. Identification of underlying mechanisms and environmental determinants of FA and...
13.
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment
Simpson E, Schlievert P, Yoshida T, Lussier S, Boguniewicz M, Hata T, et al.
J Allergy Clin Immunol
. 2023 Jun;
152(5):1179-1195.
PMID: 37315812
Background: Atopic dermatitis (AD) is an inflammatory disorder characterized by dominant type 2 inflammation leading to chronic pruritic skin lesions, allergic comorbidities, and Staphylococcus aureus skin colonization and infections. S...
14.
Sever M, Calatroni A, Roberts G, Du Toit G, Bahnson H, Radulovic S, et al.
J Allergy Clin Immunol Pract
. 2023 May;
11(7):2217-2227.e9.
PMID: 37146884
Background: The Learning Early About Peanut Allergy (LEAP) study team developed a protocol-specific algorithm using dietary history, peanut-specific IgE, and skin prick test (SPT) to determine peanut allergy status if...
15.
Dapas M, Thompson E, Wentworth-Sheilds W, Clay S, Visness C, Calatroni A, et al.
PLoS Genet
. 2023 Jan;
19(1):e1010594.
PMID: 36638096
Impaired lung function in early life is associated with the subsequent development of chronic respiratory disease. Most genetic associations with lung function have been identified in adults of European descent...
16.
Altman M, Kattan M, OConnor G, Murphy R, Whalen E, LeBeau P, et al.
Lancet Planet Health
. 2023 Jan;
7(1):e33-e44.
PMID: 36608946
Background: Asthma prevalence and severity have markedly increased with urbanisation, and children in low-income urban centres have among the greatest asthma morbidity. Outdoor air pollution has been associated with adverse...
17.
Limjoco J, Calatroni A, Aristizabal P, Thornburg C
Haemophilia
. 2022 Dec;
29(1):51-60.
PMID: 36469856
Introduction: To inform education and treatment discussions, it is important to understand how persons with haemophilia prefer to learn about and discuss new therapies and to identify variables that influence...
18.
Jackson D, Bacharier L, Gergen P, Gagalis L, Calatroni A, Wellford S, et al.
Lancet
. 2022 Aug;
400(10351):502-511.
PMID: 35964610
Background: Black and Hispanic children living in urban environments in the USA have an excess burden of morbidity and mortality from asthma. Therapies directed at the eosinophilic phenotype reduce asthma...
19.
Fulkerson P, Lussier S, Bendixsen C, Castina S, Gebretsadik T, Marlin J, et al.
medRxiv
. 2022 Jul;
PMID: 35860216
The Human Epidemiology and Response to SARS-CoV-2 (HEROS) is a prospective multi-city 6-month incidence study which was conducted from May 2020-February 2021. The objectives were to identify risk factors for...
20.
Seibold M, Moore C, Everman J, Williams B, Nolin J, Fairbanks-Mahnke A, et al.
J Allergy Clin Immunol
. 2022 Jun;
150(2):302-311.
PMID: 35660376
Background: Whether children and people with asthma and allergic diseases are at increased risk for severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection is unknown. Objective: Our aims were to...